Autoimmune Hepatitis Management: Recent Advances and Future Prospects.
| Autor: | Sierra, Rebeca, Marenco-Flores, Ana, Alsaqa, Marwan, Barba, Romelia, Cuellar-Lobo, Marcela, Barberan, Carla, Sierra, Leandro |
|---|---|
| Předmět: |
BIOPSY
ADRENOCORTICAL hormones CIRRHOSIS of the liver DISEASE management IMMUNOGLOBULINS CHRONIC active hepatitis DISEASE remission TREATMENT effectiveness METHYLTRANSFERASES AZATHIOPRINE METABOLIC syndrome SERODIAGNOSIS LIVER function tests LIVER transplantation GLUCOCORTICOIDS TUMOR necrosis factors PHARMACODYNAMICS CHEMICAL inhibitors DISEASE complications SYMPTOMS |
| Zdroj: | Livers; Jun2024, Vol. 4 Issue 2, p240-252, 13p |
| Abstrakt: | Autoimmune hepatitis (AIH) is a varied inflammatory chronic liver disease. AIH's prevalence varies and has increased recently. Diagnosis involves the discovery of histologic features following liver biopsy and serologic testing. Clinical features vary, and up to 40% of patients may be asymptomatic. Evaluating thiopurine methyltransferase (TMPM) activity before treatment is crucial for an optimal response. The primary treatment goal is biochemical remission, normalized serum IgG, and liver enzymes. Induction therapy typically involves azathioprine and corticosteroids. Close monitoring of liver function tests and serum immunoglobulin levels is essential. Medications can be tapered after achieving biochemical remission. Liver transplantation may be required for refractory disease or cirrhosis. Further therapeutic approaches are needed, particularly for non-responders to first-line treatments. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|